F
Fausto G. Araujo
Researcher at Palo Alto Medical Foundation
Publications - 120
Citations - 5333
Fausto G. Araujo is an academic researcher from Palo Alto Medical Foundation. The author has contributed to research in topics: Toxoplasma gondii & Antigen. The author has an hindex of 45, co-authored 120 publications receiving 5206 citations. Previous affiliations of Fausto G. Araujo include Swedish University of Agricultural Sciences & Stanford University.
Papers
More filters
Journal Article
IL-10 is required to prevent immune hyperactivity during infection with Trypanosoma cruzi.
Christopher A. Hunter,L A Ellis-Neyes,T Slifer,S Kanaly,G Grunig,M Fort,Donna Rennick,Fausto G. Araujo +7 more
TL;DR: It is demonstrated for the first time that during infection with T. cruzi there is a critical requirement for IL-10 to prevent the development of a pathologic immune response associated with CD4+ T cells and overproduction of IL-12.
Journal Article
Western Blot analysis of the antigens of Toxoplasma gondii recognized by human IgM and IgG antibodies.
TL;DR: Western Blot analysis revealed that both IgM and IgG antibodies present in the sera of humans infected with Toxoplasma gondii recognize three major antigens with apparent m.w. of 32,000, 22, thousands, and 6000, respectively, and at least 17 other antigenic components.
Journal ArticleDOI
Remarkable in vitro and in vivo activities of the hydroxynaphthoquinone 566C80 against tachyzoites and tissue cysts of Toxoplasma gondii.
TL;DR: Results reveal remarkable in vitro and in vivo activities of 566C80 against Toxoplasma gondii, and mortality as well as clinical signs of brain infection was absent from treated mice, whereas control mice had a high mortality rate and showed clinicalSigns of central nervous system infection.
Journal ArticleDOI
Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population.
TL;DR: In this article, the authors defined the serologic criteria for diagnosis of toxoplasmosis in heart transplant recipients, and found that serologic changes occurred more often in patients who received azathioprine, corticosteroids, and antithymocyte globulin than in those who received cyclosporine and cyclophosphamide.
Journal Article
Primary and Reactivated Toxoplasma Infection in Patients with Cardiac Transplants
TL;DR: The data show the wide clinical spectrum and differences in kinetics of antibody response of patients who develop toxoplasma infection after transplantation, and suggest that clinical disease occurs in those who have seroconversion but is rare in patients with preexisting antibody who haveSerologic evidence of recrudescence.